Role of oxidative stress in pathogenesis of coronary spasm, a molecular biological and clinical study

氧化应激在冠状动脉痉挛发病机制中的作用,分子生物学和临床研究

基本信息

  • 批准号:
    11670693
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

We examined the effect of reduced glutathione (GSH), an important antioxidant which restores intracellular redox imbalance and prevents inactivation of endothelial-derived nitric oxide, on the abnormal vasomotor reactivity in spasm coronary arteries. Responses of epicardial diameter of the left coronary arteries to intracoronary infusion of acetylcholine (ACh, 50μg/min) were measured by quantitative coronary angiography before and during combined intracoronary infusion of GSH (50mg/min, 6 min) or saline as a placebo in 24 patients with coronary spastic angina (CSA) and in 28 control patients. All of the spasm coronary arteries showed constrictor response to ACh, while the control coronary arteries as a whole showed only minimal diameter changes to ACh. GSH infusion suppressed constrictor response of epicardial diameter to ACh in patients with CSA, while it had no significant effect in control subjects. Saline infusion did not have any effects. The results indicate that GSH attenuated constrictor response to ACh in epicardial coronary arteries of patients with CSA.GSH may have an important role in the regulation of coronary vasomotor function in patients with CSA.Oxidized low-density lipoproteins (LDL) impair endothelium-dependent dilation and constrict arteries. This study examined possible relation of the circulating plasma levels of Ox-LDL to CSA.The plasma levels of Ox-LDL were measured by ELISA in 37 consecutive patients with CSA and normal coronary angiograms and in 79 consecutive control patients. The Ox-LDL levels in patients with CSA were significantly higher than those in controls. In multivariate analysis, higher levels of Ox-LDL were a risk factor for CSA independently of other traditional risk factors. The Ox-LDL levels had a significant and positive correlation with constrictor response of coronary arteries to the intracoronary acetylchnoline infusion. Thus, Ox-LDL may play a possible role in pathogenesis of coronary spasm.
还原性谷胱甘肽(GSH)是一种重要的抗氧化剂,可以恢复细胞内氧化还原失衡,防止内皮来源的一氧化氮失活,我们研究了还原性谷胱甘肽(GSH)对痉挛冠状动脉异常血管舒张反应性的影响。采用定量冠状动脉造影法测定24例冠心病痉挛性心绞痛(CSA)患者和28例对照患者冠脉内联合输注GSH (50mg/min, 6 min)或生理盐水(安慰剂)前后左冠状动脉心外膜直径对乙酰胆碱(ACh, 50μg/min)的反应。所有痉挛冠状动脉对乙酰胆碱均表现出收缩反应,而对照组冠状动脉对乙酰胆碱的直径变化很小。GSH输注抑制CSA患者心外膜直径对乙酰胆碱的收缩反应,而对对照组无显著影响。生理盐水输注无任何影响。结果表明,谷胱甘肽能减弱CSA患者心外膜冠状动脉对乙酰胆碱的收缩反应。谷胱甘肽可能在CSA患者冠状动脉血管舒缩功能的调节中起重要作用。氧化低密度脂蛋白(LDL)损害内皮依赖性扩张和动脉收缩。本研究探讨了循环血浆Ox-LDL水平与CSA的可能关系。采用酶联免疫吸附试验(ELISA)测定了37例CSA合并冠状动脉造影正常患者和79例对照患者的血浆Ox-LDL水平。CSA患者的Ox-LDL水平明显高于对照组。在多因素分析中,高水平的Ox-LDL是CSA的危险因素,独立于其他传统危险因素。Ox-LDL水平与冠状动脉对乙酰胆碱灌注的收缩反应呈显著正相关。因此,Ox-LDL可能在冠状动脉痉挛的发病机制中起作用。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kiyotaka Kugiyama, et al.: "Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina."American Journal of Physiology.. 280. H264-71 (2001)
Kiyotaka Kugiyama 等人:“谷胱甘肽可减弱冠状动脉痉挛性心绞痛患者对乙酰胆碱的冠状收缩。”美国生理学杂志.. 280. H264-71 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kiyotaka Kugiyama: "Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease."Circulation. 99. 2858-2860 (1999)
Kiyotaka Kugiyama:“空腹血清中的残余脂蛋白水平可预测冠状动脉疾病患者的冠状动脉事件。”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hideki Doi: "Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism."Circulation. 102. 670-676 (2000)
Hideki Doi:“残余脂蛋白通过氧化还原敏感机制诱导内皮细胞中促动脉粥样硬化血栓形成分子。”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kiyotaka Kugiyama: "Circulating Levels of Secretory Type II Phospholipase A2 Predict Coronary Events in Patients with Coronary Artery Disease."Circulation. 100. 1280-1284 (1999)
Kiyotaka Kugiyama:“分泌型 II 型磷脂酶 A2 的循环水平可预测冠状动脉疾病患者的冠状动脉事件。”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yuji Miyao: "Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina."Journal of American College Cardiology. 36. 432-437 (2000)
Yuji Miyao:“冠状动脉痉挛性心绞痛患者的冠状动脉弥漫性内膜增厚。”美国大学心脏病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUGIYAMA Kiyotaka其他文献

KUGIYAMA Kiyotaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUGIYAMA Kiyotaka', 18)}}的其他基金

A study of role of phospholipase A2 receptor in pathogenosis ofcardiovascular diseases and development of new drug for cardiovascular diseases
磷脂酶A2受体在心血管疾病发病机制中的作用研究及心血管疾病新药开发
  • 批准号:
    22390158
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A study of role of phospholipase A2 in pathogenosis of cardiovascular diseases and development of new drug for cardiovascular diseases
磷脂酶A2在心血管疾病发病中的作用研究及心血管疾病新药开发
  • 批准号:
    19390209
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical significance of remnant lipoproteinemia as a therapeutic target of cardiovascular diseases
残余脂蛋白血症作为心血管疾病治疗靶点的临床意义
  • 批准号:
    15390244
  • 财政年份:
    2003
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of polymorphisms of γ-glutamylcysteine synthetase genes in pathogenesis of coronary spastic angina
γ-谷氨酰半胱氨酸合成酶基因多态性在冠状动脉痉挛性心绞痛发病机制中的作用
  • 批准号:
    13670728
  • 财政年份:
    2001
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of remnant lipoproteins on functions of endothelial cells, smooth muscle
残余脂蛋白对内皮细胞、平滑肌功能的影响
  • 批准号:
    09670730
  • 财政年份:
    1997
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of lysolecithin on the regulation of gene transcription in endothelial cells and plasma levels of secretary type II phospholipase A2 in coronary artery disease
溶血卵磷脂对冠心病内皮细胞基因转录及血浆分泌型II型磷脂酶A2水平的影响
  • 批准号:
    07670793
  • 财政年份:
    1995
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of natriuretic peptides on the mechanisms of atherosclerosis
利钠肽对动脉粥样硬化机制的影响
  • 批准号:
    05670622
  • 财政年份:
    1993
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Effects of oxidized low density lipoprotein on vascular endothelial and smooth muscle cells
氧化低密度脂蛋白对血管内皮和平滑肌细胞的影响
  • 批准号:
    03670460
  • 财政年份:
    1991
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
  • 批准号:
    23K21458
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
  • 批准号:
    10643012
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
LRRK2 and oxidative stress in Parkinson’s disease
LRRK2 与帕金森病的氧化应激
  • 批准号:
    10799999
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies
开发妊娠期特异性胎盘器官芯片来模拟健康和氧化应激以及炎症相关的病理学
  • 批准号:
    10732666
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
IntBIO: Collaborative Research: Integrating nanobiotechnologies to understand the role of nitro-oxidative stress in the coral-dinoflagellate mutualistic symbiosis dynamics
IntBIO:合作研究:整合纳米生物技术来了解硝基氧化应激在珊瑚-甲藻互利共生动态中的作用
  • 批准号:
    2316389
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Standard Grant
Investigation of the effects of macrolide antimicrobial agents on oxidative stress tolerance in trophoblast cells
大环内酯类抗菌药物对滋养层细胞氧化应激耐受性影响的研究
  • 批准号:
    23K08863
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Determining the role of Rac1 palmitoylation in cardiac hypertrophy and oxidative stress
确定 Rac1 棕榈酰化在心脏肥大和氧化应激中的作用
  • 批准号:
    10534386
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Placental identified NHIP regulating neuronal oxidative stress in autism
胎盘发现 NHIP 调节自闭症神经元氧化应激
  • 批准号:
    10717990
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
The role of oxidative stress in reduced microvascular function after gestational diabetes
氧化应激在妊娠糖尿病后微血管功能下降中的作用
  • 批准号:
    10712433
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Structural systems biology of microenvironmental oxidative stress and synthetic biology intervention
微环境氧化应激的结构系统生物学与合成生物学干预
  • 批准号:
    10715112
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了